Relationship between power law coefficients and major blood constituents affecting the whole blood viscosity |
Mohammad A Hussain*, Subir Kar and Ram R Puniyani
School of Biomedical Engineering, Indian Institute of Technology Bombay, Mumbai 400 076, India
*Corresponding author (Fax, 91-22-5783480; Email, asif@cc.iitb.ernet.in).
The present work concerns a quantitative analysis of parameters that affect apparent blood viscosity at different low shear rates, i.e, between 1 s1 and, 100 s1. Viscosity profile of a large number of blood samples from thromboembolic stroke cases and age and sex matched healthy controls were studied which confirmed non-Newtonian power law behaviour of blood. The power law coefficients, n and k, which are unique to each blood sample, were related with blood viscosity parameters in the form of a mathematical equation by performing non-linear regression analysis. It was possible to calculate n and k of power law model by supplying the values of major blood constituents in the equation obtained for stroke and controls. The calculation of n and k of a blood sample using the equation obtained, provided a quick information on its apparent viscosity values at any given shear rate without viscometry. The calculated and the experimental viscosity were found in good agreement within a permissible error range. The relation obtained between power law coefficients and major blood constituents in the present investigation would give a quantification of different blood viscosity parameters contributing to the resistance to flow of blood. Such an analysis may be considered as a scientific basis for the study of blood fluidity in different disease conditions.
Mathematically the inverse of blood fluidity is known as the whole blood viscosity. Viscosity is that property of fluid by virtue of which it offers resistance to flow or shear. The viscosity of whole blood is influenced by a number of blood constituents like haematocrit (% packed red cell volume), plasma proteins, temperature and shear rates. The dependence of blood viscosity on the shear rate or the non-Newtonian nature of blood has been reported by many workers. For instance, the viscosity of blood increases with decrease in shear rates and vice versa showing that blood behaves as a non-Newtonian fluid (Charm and Kurland 1974; Cokelet 1972; Dintenfass 1972; Merill 1969).
1.1 Power law model
The apparent whole blood viscosity, which is the ratio of shear stress to shear rate at a particular rate of shear, can be expressed as:
t /(du/dy) = m a, (1)
where, m a = apparent viscosity or structural viscosity.
In case of Newtonian fluid: m a = m .
The apparent blood viscosity is computed as the ratio of the measured shear stress existing at a given shear rate, to the shear rate itself as
m a = k(du/dy)(n 1). (2)
Taking logarithm on both sides of equation (2), we have
log m a = log k + (n 1) log(du/dy), (3)
when k = 1 is substituted in equation (3) then log k = 0, and equation (3) changes to
log m a = (n 1) log(du/dy). (4)
The slope (n 1) is calculated from equation (4). By substituting the value of n obtained, intercept k is found from equation (3).
Thus by plotting the log m a and log(du/dy) it is possible to obtain n and k for each blood samples by linear least square regression method reported at length elsewhere (Hussain et al 1994).
1.2 Physiological meaning of n and k
The parameters n and k are the power law coefficients and represent resistance to flow of the blood. The n is defined as non-Newtonian behaviour index and is a dimensionless quantity, while k is described as flow consistency index and its unit is mPa.Sn. They explain more explicitly, the behaviour of blood over a range of shear rates (Hussain et al 1994).
1.3 Genesis of the problem
Although there are recommendations of International Committee for Measurements of Blood Viscosity (ICSH, 1986), the interpretation and comparison of clinical whole blood viscosity data are not satisfactory. This is because workers in this field generally, while reporting viscosity values have used one or two different particular shear rates (Walker et al 1985; Lechner et al 1986; Ott et al 1986; Caimi et al 1987; Ernst et al 1987; Fisher et al 1987). There has been no agreement about the shear rates at which the viscosity should be compared between two given samples (Inglis et al 1981). Therefore, the consideration of a range of shear rates and averaging out the resulting viscosity values by finding the best fit for the data was tried out in the past. Charm and Kurland (1962) suggested that shear rate versus apparent blood viscosity data followed power law. This was supported by Benis et al (1971). Bernasconi et al (1986, 1989, 1991) and Kar et al (1991) have shown that power law regression method is suitable for blood viscosity quantification. Bernasconi et al (1986, 1989, 1991) conducted their series of experiment taking exclusively normal blood samples while Kar et al (1991) and later Hussain et al (1994) of the same research group have conclusively proved that not only normal blood but other pathological blood also follow power law model. The results obtained are extremely useful for understanding rheological behaviour of blood.
A few studies exist which find the correlation of power law coefficients with haematological and biochemical parameters in the form of constitutive equation (Walburn and Schneck 1976; Easthope and Brooks 1980). Easthope and Brooks (1980) have used a constitutive function first employed by Walburn and Schneck (1976) describing the flow properties of whole blood which relates the shear stress measured in a viscometer to the shear rate and haematocrit of the sample. In the present work, however, we have tried to find out a mathematical equation by performing non-linear regression analysis. Since the n of power law model is the non-Newtonian behaviour index and k is the flow consistency index of blood, they are naturally dependent on the constituents of blood such as haematocrit, fibrinogen, cholesterol etc. It is possible to have such relationship between power law coefficients and the above mentioned parameters in the form of a mathematical equation by using non-linear regression analysis. As a continuation of our previous studies (Hussain et al 1994, 1995) we have considered blood samples of cerebrovascular disease only along with normal controls for the present analysis.
2. Patients and methods
2.1 Selection of patients and controls
Patients admitted to a major hospital in Bombay with a fresh thromboembolic stroke (less than 24 h old at the time of the first blood collection) were included in this study. A total of 150 cerebrovascular accident (CVA) cases were studied. Apart from this, 109 healthy volunteers were also studied as control. All controls were age and sex-matched and are shown in table 1.

2.2 Selection criteria
2.2a CVA cases: Although it is not possible to distinguish reliably a cerebral haemorrhage from infarction on clinical grounds alone, the features usually associated with haemorrhage as explained by WHO were considered primarily to screen out haemorrhagic cases (WHO 1989). Over and above the WHO criteria, a CT scan was performed to rule out intra-cranial haemorrhage in the cases included in the analysis. A detailed history was taken and a thorough clinical examination was done in the case of each patient. All patients were investigated with a haemogram, blood urea nitrogen, creatinine, fasting blood sugar (FBS) (Daniel 1983), plain chest X-ray and ECG. Patients with a BUN : serum creatinine ratio of 20 : 1, indicative of dehydration were excluded from the study.
2.2b Healthy controls: Clinically normal aged volunteers were included in this control group so as to match with the patients age and also to nullify the well-known effect of age on the disease.
2.3 Laboratory methods
Different laboratory methods to evaluate patients and controls used in this study are mentioned below.
2.3a Anticoagulant: EDTA was used as an anticoagulant for all analyses.
2.3b Haemorheological studies
(i) Whole blood viscosity
Instrument used: Contraves, low shear 30 viscometer (Zurich, Switzerland): This instrument was used for the study of whole blood viscosity. A stationary bob within a rotating cup, produces shear force in sample fluid contained in the cup. The viscosity of the fluid generates resistance to the rotating cup proportional to the shear rate. Readings can be taken at different shear rates from 0·017 s1 to 128·5 s1. Sample is kept at 37°C in a temperature bath. The amount of torque produced by the resistance is indicated on a digital display. This is easily converted into absolute centipoise units from precalculated range chart available with the instrument.
Method: Six ml of venous blood collected with a dry disposable syringe in an EDTA plastic bulb from patients and controls, were subjected to 7 different shear rates namely, 1·285/s, 3·23/s, 4·39/s, 8·11/s, 20·4/s, 51·2/s and 94·5/s and viscosity was calculated as described above.
(ii) Method of viscometric data analysis: Apparent blood viscosity values corresponding to above mentioned seven shear rates were plotted against these shear rates on loglog scale. Thus by plotting the log m a and log(du/dy) it was possible to obtain n and k of power law for the blood samples by linear least square regression method and this has been reported elsewhere (Hussain et al 1994).
2.3c Haematocrit and biochemical parameters: Haematocrit was estimated using capillary haematocrit method at 17,000 rpm (Micro Centrifuge, RM 12, Remi). Fibrinogen and cholesterol were estimated using routine laboratory methods.
2.4 Quantification of blood viscosity parameters
using n and k of power law
As we have proposed in the present work n and k may be related in the form of an equation and may be estimated as functions of blood viscosity parameters (blood constituents) mainly haematocrit, fibrinogen and cholesterol. The reason for selecting these three parameters are discussed in § 4.
We can write,
k = a (Hct, Chol, Fibrn, . . .). (5)
Similarly,
n = b (Hct, Chol, Fibrn, . . .). (6)
Fibrinogen and chololesterol are measured in mg/dl, while k has a unit mPa.sn. Haematocrit is represented in per cent. As can be seen, the equations (5 and 6) are dimensionally inconsistent. Since any equation, which is physically true should also be dimensionally consistent so Raleighs method (Maurice 1961) can be applied according to which equations (5 and 6) are written as follows:
k = a (Hcta1 Chola2 Fibrna3 . . .) (7)
and
n = b (Hctb1 Cholb2 Fibrnb3 . . .). (8)
In order to make parameters on both the sides dimension-less they are divided by a constant value of healthy subjects. For example,
K = k/kn
where, kn is average value of flow consistency index of healthy controls. The average value taken is 17·0 mPa.sn for kn in order to make k a dimensionless quantity denoted as K by taking ratio of k : kn. Similarly fibrinogen and cholesterol are made dimensionless by taking constant values in the normal range as follows:
Fibrn' = Fibrn/Fibrnnwhere Fibrnn = 200 mg/dl
Chol' = Chol/Cholnwhere Choln = 150 mg/dl.
Now the equations (7 and 8) can be written as,
k/kn = a {Hct, (Chol/Choln), (Fibrn/Fibrnn), . . .} (9)
n = b {Hct, (Chol/Choln), (Fibrn/Fibrnn), . . .}. (10)
These can also be written as follows:
K = a ( Hcta1 Chol' a2 Fibrn' a3 . . .) (11)
and
n = b (Hctb1 Chol' b2 Fibrn' b3 . . .). (12)
Coefficient and exponents of equations (11 and 12) is obtained using nonlinear regression method for a particular set of experimental data of patients and controls as follows.
2.5 Calculation of coefficient and exponents
The subroutine RNLIN of IMSL (International Mathematical and Statistical Library) is used to calculate coefficient and exponents in the present analysis through optimization technique (IMSL 1987a). The n, K and corresponding Hct, Chol', Fibrn' data from 150 CVA cases and 134 normal subjects were used to find the best fit equation viz., equations (11 and 12), and the values of coefficients and exponents involved therein. The obtained values of coefficient and exponents was used to calculate the n and K values of fresh blood samples by feeding Hct, Chol', Fibrn' data from CVA and normal control as mentioned below.
2.5a Reliability of the analysis: To check the reliability of the present analysis and uniqueness of the coefficient and exponents, fresh samples of CVA cases (N = 43) as well as healthy controls (N = 36) were estimated for Hct, Fibrn and Chol. Dimension-less values of these blood viscosity parameters e.g., Hct, Fibrn', Chol' were supplied in the equation and using respective coefficients and exponents of CVA group of patients and healthy control group, n and K were calculated. These samples were also experimentally analysed using viscometer and n and K were estimated directly to check the reliability of our analysis.
2.5b Justification for the IMSL subroutine RNLIN used in the present investigation: The method of simulation is primarily selected on the basis of degree of accuracy and reliability of the solution obtained. In the first attempt IMSL subroutine RNLIN which involves nonlinear regression using least square method was used and coefficients were obtained. Now to check the reliability and accuracy of the solution two other methods were used. One was IMSL subroutine UMPOL, which used simplex optimization routine (IMSL 1987a) and another subroutine used was DFPMIN (William 1986), which is based on BroydenFletcherGoldfarbShanno variant of DavidonFletcherPowell minimization. However both the methods yielded identical results with those given by IMSLs RNLIN subroutine. All simulations to calculate coefficients and exponents were done using subroutine RNLIN because of easy handling of IMSL package. In other words, the simplicity of RNLIN over UMPOL favoured the use of former subroutine.
3. Results and discussion
The parameters n and k represent
resistance to flow of blood. They explain more explicitly, the cumulative behaviour of
blood constituents over a range of shear rates. We have selected mainly three blood
viscosity parameters to be correlated with n and k in the present study.
These blood viscosity parameters are haematocrit, fibrinogen and cholesterol and, are
estimated routinely in clinical laboratories. Haematocrit is nothing but the percentage
packed volume of red blood cells and a major contribution to whole blood viscosity comes
from it. This parameter includes not only the effect of packed cell volume of red blood
cells but, also
other important physical parameters namely, aggregability, filterability/deformability and
rigidity or internal viscosity of red blood cells. These physical parameters in turn are
affected by the alteration in the concentration of biochemical factors in plasma or
plasmatic factors. For instance, red blood cell aggregability which is induced by
fibrinogen, is well documented. Similarly, red blood cell filterability/deformability and
rigidity are not only influenced by external and internal constituents of red blood cells
but to a larger extent by the membrane characteristics (Lange et al 1982; Garnier et
al 1985; Annapurna et al 1990). A red cell has a semipermeable membrane whose
chemical composition mainly constitutes cholesterol and phospholipid. Any alteration in
cholesterol concentration in plasma may effect the ratio of cholesterol: phospholipid in
the lipid bilayer and the lipid bilayered matrix depending upon this ratio may influence
the red cell deformational properties (Lange et al 1982; Garnier et al 1985;
Annapurna et al 1990). Hence, we have selected fibrinogen and cholesterol along
with haematocrit as major factors contributing to blood viscosity. Our study focuses on
the quantification of these three parameters and, has shown their contributions to blood
viscosity as values of their exponents in the equation relating to n and K (tables
2 and 3).
The table 1 presents the mean age and sex composition of CVA cases (N = 150) and normal controls (N = 134) considered for the calculation of coefficients and exponents involved in the equations (11 and 12) as shown in the tables (2 and 3). This is apparent from the tables (2 and 3) that the two populations, viz., normal control and CVA cases differ by their respective coefficients and exponents involved in the equations (11 and 12) relating n and K with haematocrit and biochemical factors. The most significant contribution in the calculation of both n and K comes actually from haematocrit. The normalized flow consistency index K, in case of healthy controls depends on haematocrit raised to a power of almost double to that of haematocrit power in case of CVA cases. This may relate to deformable normal red cells ability to consistently contribute to flow consistency with increasing shear rate, while a less deformable, rigid red cells as in CVA cases contribute to a lower degree to flow consistency index. Cholesterol shows its contribution more in CVA cases, which may be attributed indirectly to red cell rigidity as a result of disturbed cholesterol and phospholipid ratio in the red cell membrane (Annapurna et al 1990).

The tables (4 and 5) show the comparison of experimentally obtained n and K values with that of the theoretically calculated n and K values, in CVA cases and normal controls respectively. The standard deviation and the percentage error of the difference between experimentally estimated n, K values and theoretically calculated n, K values are found within permissible error range (tables 4 and 5).
Although shear rates less than 1 s1 and higher than 100 s1 are very important for any clinical study, we have not selected them because the power law model does not allow investigation on these ranges of shear rates. However, the present consideration of the range of shear rates, between 1 s1 and 100 s1 do have prognostic importance in early detection of the episode. Moreover, it serves our purpose to make investigation on the relationship between power law coefficients and blood viscosity parameters based on group study of a particular type of disease or population. This type of relation would allow the calculation of n and k of power law of any fresh blood sample falling in a particular group. Major routine biochemical parameters and haematological values can be supplied in the relation obtained, in order to calculate n and k of the power law. Once n and k become known, the apparent viscosity may be calculated at any desired shear rate, thus providing quick information about apparent whole blood viscosity at a particular shear rate without viscometry. This is demonstrated and discussed in the following section.
3.1 Calculation of viscosity without viscometry
The calculated n and K are obtained by supplying Hct, Fibrn' and Chol' values in the equations (11 and 12) for five fresh normal and five fresh CVA cases. The values of coefficients supplied to these equations are taken from respective tables (2 and 3) for normal and CVA cases. Apparent whole blood viscosity is calculated for these cases at 7 different shear rates using calculated n and K . Thus, theoretically calculated apparent whole blood viscosity, using proposed equation, matches with that of experimentally obtained value of the same subjects through viscometry.
Experimental values of apparent whole blood viscosity and shear-rates plot are superimposed on to the theoretically calculated values of apparent whole blood viscosity at 7 different shear rates for CVA cases and healthy controls as shown in figures 1ae and 2ae.


4. Conclusion
The present study concludes the following:
(i) All CVA and healthy blood samples behave as non-Newtonian power law fluid. The n and k are related with major blood constituents through equations (11 and 12) where, the coefficient and exponents involved are unique to the group of cases studied. These coefficient and exponents may be different in different disease conditions, which may be investigated.
(ii) The value of coefficients and exponents involved in the relation which are unique to the groups of cases studied gives a quantification of blood viscosity parameters considered in the present relation namely, fibrinogen, cholesterol and haematocrit. In other words the contribution to the resistance to flow of blood in CVA cases comes mainly from these three blood viscosity parameters. Such an analysis may be considered as a scientific basis for the study of blood fluidity in different disease conditions.
(iii) The quantitative relationship of n, k with blood constituents viz., Hct, Fibrn and Chol makes it possible to calculate apparent whole blood viscosity (BV) of a blood sample without viscometry.
AcknowledgmentsAuthors gratefully acknowledge the financial support for this work from the Council of Scientific and Industrial Research, New Delhi, Scientist Pool Scheme (No. 7233A). Partial support comes from the Department of Science and Technology, New Delhi project under Young Scientist Scheme (HR/OY/E-05/97).
References
Annapurna V, Puniyani R R and Gupte R V 1990 Red cell deformability and erythrocyte lipids in hypertension; Clin. Hemorheol. 10 95101
Benis A M, Usami S and Chien S 1971 Determination of shear stress shear rate relation for blood by couette viscometry; Biorheology 8 6569
Bernasconi C, Del Santo A, Marralli F and Agostoni A 1989 Standardized correction of whole blood viscosity for the main determinants: a computerized system; Clin. Hemorheol. 9 633640
Bernasconi C, Del Santo A, Marralli F, Laffranchi M, Mitani S and Agostoni A 1991 Reference limits for blood viscosity influence of sex and age; Clin. Hemorheol. 11 447457
Bernasconi C, Ferraresi, Agostoni A 1986 Power law regression method for blood viscosity quantification; Clin. Hemorheol. 6 541551
Caimi G, Savettieri G, Fierro B, Catania A and Sarno A 1987 Multiple Sclerosis: Haemorheological Pattern; Clin. Hemorheol. 7 695698.
Charm S E and Kurland G S 1962 The flow behavior and shear stress, shear rate characteristics of canine blood; Am. J. Physiol. 203 417421
Charm S E and Kurland G S 1974 Blood flow and microcirculation (New York: Wiley)
Cokelet G R 1972 Its foundations and Objectives; in Biomechanics (eds) Y C Fung, N B Perrone and M Anlinker (Englewood Cliffs, New Jersey: Prentice Hall) pp 63103
Daniel W F 1983 Diabetes mellitus; in
Harrisons principles of internal medicine (eds) W T George, D A Raymond,
B Eugene, K J Isselbacher and G P Robert (New York: McGraw-Hill Kogakusha Ltd: A Blakiston
Publication) 8th edition, pp 661678
Dintenfass L 1972 Blood microrheology Viscosity factors in blood flow, ischemia and thrombosis (London: Butterworth)
Easthope P L and Brooks D E 1980 A Comparison of Rheological Constitutive Functions for Whole Human Blood; Biorheology 17 235247
Ernst E, Thies W, Matrai A, Seichert N, Schöps P, Magyarosy I, Kraft-Kupfer A and Schattenkirchner M 1987 Hemorheological Abnormalities in Rheumatoid Arthritis; Clin. Hemorheol. 7 591598
Fisher M, Giannotta S and Meiselman H J 1987 Hemorheological Alterations in Patients with Subarachnoid Hemorrhage; Clin. Hemorheol. 6 611618
Garnier M, Koutrsouris D and Hanss M 1985 On the membrane determinant of erythrocyte deformability; Clin. Hemorheol. 5 401409
Hussain M A, Puniyani R R and Kar S 1994 Quantification of blood viscosity using power law model in cerebrovascular accidents and high risk controls; Clin. Hemorheol. 14 685696
Hussain M A, Puniyani R R and Kar S 1995 Blood viscosity autoregulation factor in cerebrovascular accidents and high risk cases A new approach; Clin. Hemorheol. 15 6171
ICSH (International Committee for Standardization in Haematology) 1986 Expert Panel on Blood Rheology, "Guidelines for measurement of blood viscosity and erythrocyte deformability"; Clin. Hemorheol. 6 439453
IMSL 1987a Problem-solving Software System, MATH/ LIBRARY: FORTRAN Subroutines for Statistical Analysis; Softcover Edition (Control Data Corporation Publication Number 41621852, version 1·0 MALB-USM-PERFECT-1·0) pp 831834
IMSL 1987b Problem-solving Software System, STAT/ LIBRARY: FORTRAN Subroutines for statistical analysis; Softcover Edition (Control Data Corporation Publication Number 41621852, version 1·0 STLIB-USM-PERFECT-1·0) pp 239247
Inglis T C, Carson P J and Sturat J 1981 Clinical measurement of whole blood viscosity at low shear rates; Clin. Hemorheol. 1 167177
Kar S, Mehta J and Sharma K 1991 Investigation on non-Newtonian behaviour of normal and leukemic blood, in Proceeding of 13 Annual International Conference IEEE Engineering in Medicine and Biology (Orlando, USA) vol. 13 (5), pp 19911992
Lange Y, Gouch A and Steck T L 1982 Role of the bi-layer in the shape of the isolated erythrocyte membrane; J. Membr. Biol. 69 113123
Lechner H, Ott E, Ossama N and Fazekas F 1986 Round table: Follow up studies of the haemorheologic profile in acute ischaemic strokes; Clin. Hemorheol. 6 39
Maurice H 1961 Dimensional Analysis, in Handbook of fluid dynamics, First edition, (ed.) V L Streeter (New York: McGraw-Hill) pp 15.115.25
Merill E W 1969 Rheology of blood; Physiol. Rev. 49 863888
Ott E, Niederkorn K, Fazekas F, Körner E, Ossama N and Lechner H 1986 The implication of hemorheologic abnormalities in cerebrovascular disease; Clin. Hemorheol. 6 331336
Walburn F J and Schneck D J 1976 A constitutive equation for whole human blood; Biorheology 13 201210
Walker T, Matrai A, Flute P T and Dormandy J A 1985 Hemorheological and functional changes in intermittent claudication following plasma exchange with haematocrit; Clin. Hemorheol. 5 99106
WHO 1989 Stroke prevention, diagnosis and therapy; Stroke 20 14071434
William H P 1986 Minimization of
Functions The BroydenFletcherGoldfarb Shanno variant of
DavidsonFletcher-Powell minimization; in Numerical recipes; The Art of scientific
computing (eds) H P William, P F Brian, A T Saul and T V William (Cambridge:
University Press) pp 310
311
MS received 4 December 1998; accepted 25 June 1999
Corresponding editor: Albert Goldbeter